CVS Health Co. (NYSE:CVS) Shares Purchased by Anchor Capital Advisors LLC

Anchor Capital Advisors LLC grew its holdings in shares of CVS Health Co. (NYSE:CVS) by 32.8% during the fourth quarter, Holdings Channel reports. The firm owned 196,577 shares of the pharmacy operator’s stock after acquiring an additional 48,545 shares during the quarter. Anchor Capital Advisors LLC’s holdings in CVS Health were worth $15,522,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also made changes to their positions in the company. Intrust Bank NA grew its position in CVS Health by 16.4% in the 4th quarter. Intrust Bank NA now owns 14,944 shares of the pharmacy operator’s stock worth $1,180,000 after purchasing an additional 2,107 shares during the last quarter. Greatmark Investment Partners Inc. grew its holdings in shares of CVS Health by 3.9% in the 4th quarter. Greatmark Investment Partners Inc. now owns 261,128 shares of the pharmacy operator’s stock worth $20,619,000 after acquiring an additional 9,868 shares during the last quarter. Choreo LLC lifted its stake in CVS Health by 95.5% during the fourth quarter. Choreo LLC now owns 13,901 shares of the pharmacy operator’s stock valued at $1,098,000 after buying an additional 6,792 shares in the last quarter. Mather Group LLC. boosted its stake in CVS Health by 36.9% in the 4th quarter. Mather Group LLC. now owns 8,085 shares of the pharmacy operator’s stock worth $638,000 after purchasing an additional 2,181 shares during the period. Finally, Eagle Wealth Strategies LLC purchased a new position in CVS Health during the 4th quarter worth approximately $595,000. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at CVS Health

In other CVS Health news, EVP Prem S. Shah sold 29,473 shares of the firm’s stock in a transaction dated Friday, February 16th. The shares were sold at an average price of $76.95, for a total transaction of $2,267,947.35. Following the completion of the transaction, the executive vice president now owns 39,765 shares in the company, valued at $3,059,916.75. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 0.24% of the stock is owned by insiders.

CVS Health Stock Performance

NYSE:CVS traded up $0.36 during trading hours on Tuesday, hitting $67.81. 1,278,076 shares of the company traded hands, compared to its average volume of 10,490,477. The company has a current ratio of 0.86, a quick ratio of 0.63 and a debt-to-equity ratio of 0.77. The stock has a market capitalization of $85.47 billion, a price-to-earnings ratio of 10.44, a P/E/G ratio of 0.89 and a beta of 0.52. The firm has a 50-day moving average of $74.22 and a 200 day moving average of $73.65. CVS Health Co. has a twelve month low of $64.41 and a twelve month high of $83.25.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, February 7th. The pharmacy operator reported $2.12 EPS for the quarter, topping analysts’ consensus estimates of $2.01 by $0.11. The company had revenue of $93.81 billion during the quarter, compared to the consensus estimate of $90.58 billion. CVS Health had a return on equity of 15.25% and a net margin of 2.33%. The company’s quarterly revenue was up 11.9% on a year-over-year basis. During the same quarter last year, the company earned $1.99 EPS. On average, analysts forecast that CVS Health Co. will post 8.31 EPS for the current year.

CVS Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 1st. Stockholders of record on Monday, April 22nd will be paid a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.92%. The ex-dividend date of this dividend is Friday, April 19th. CVS Health’s dividend payout ratio is 41.18%.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on the stock. StockNews.com lowered shares of CVS Health from a “buy” rating to a “hold” rating in a research report on Thursday, February 15th. Wells Fargo & Company dropped their price target on shares of CVS Health from $83.00 to $76.00 and set an “equal weight” rating on the stock in a research note on Monday, April 8th. Piper Sandler lifted their price objective on CVS Health from $93.00 to $94.00 and gave the company an “overweight” rating in a research report on Friday, March 15th. Leerink Partnrs reaffirmed an “outperform” rating on shares of CVS Health in a research note on Monday, February 26th. Finally, Cantor Fitzgerald reissued an “overweight” rating and issued a $87.00 price target on shares of CVS Health in a research note on Wednesday, April 10th. Four research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $89.44.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.